Summary
Decision making in renal transplantation is largely based on considerations concerning risk factors in the treatment of end-stage renal disease. The attempt to identify minimize individual risks has proven to be a key to success in renal transplantation.
Similar content being viewed by others
References
Albrechtsen D, Ludgren G, Bratlie A, Brynger H, Fehrmann I, Frödin L, Gäbel H, Lindholm A, Flatmark A (1987) Renal transplantation in presensitized patients treated with cylosporine. Transplant Proc 19(1):1862
Albrechtsen D, Fauchald P, Leivestad T, Talseth T, Flatmark A (1988) Renal replacement therapy in elderly patients. Transplant Proc 20(1)[Suppl 1]:367–369
Blohmé I, Johansson S (1981) Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy. Kidney Int 20:671–675
Braun WE, Phillips DF, Vidt DG, Novick AC, Nakamoto S, Popowniak KL, Paganini E, Magnussion M, Phl M, Steinmuller DR, Protiva D, Buszta C (1984) Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc 16(3):603–607
Bunzendahl H, Bechstein W, Wonigeit K, Robin-Winn M, Frei U, Ringe B, Pichlmayr R (1986) Effect of immunosuppression on renal allograft survival in immunized patients: a single center analysis. Transplant Proc 18(5):1067–1068
Cameron JS (1983) Effect of the recipient's disease on the results of transplantation (other than diabetes mellitus). Kidney Int 23 [Suppl 14]:24–33
Friedmann EA (1983) Clinical imperatives in diabetic nephropathy. Kidney Int 23 [Suppl 14]:16–19
Gaber AO, Thistlethwaite Jr, Haag BW, Stuart J, Mayes J, Fellner S, Stuart FP (1987) Potent immunosuppressiion overcomes retransplantation, presensitization, and histoical positive crossmatch as transplant risk factors. Transplant Proc 19(1):1915–1916
Kahan BD, Mickey R, Flechner SM, Lorber MI, Widemann CA, Kermann RH, Terasaki P, Van Buren CT (1987) Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients. Transplant Proc 19(1):1835–1838
Leumann EP, Briner J (1984) Rezidive der Grundkrankheit im Nierentransplantat. Klin Wochenschr 62:289–298
Markus BH, Mitchell S, Gordon RD, Gillquist B, Tzakis AG, Starzl TE (1988) Timy — a center-oriented transplant information management system. Transplant Proc 20(1) [Suppl 1]:385–390
Matas AJ, Tellis VA, Quinn T, Glicklich D, Sobermann R, Veith FJ (1988) The effect of referring dialysis center on cadaver kidney transplant outcome. Transplant Proc 20(1) [Suppl 1]:375–376
Najarian JS, Sutherland D, Morrow Ch, Ferguson R, Simmons RL (1983) Kidney transplants for high-risk patients. Kidney Int 23 [Suppl 14]:10–15
Opelz G (1988) Priority allocation of cadaver kidneys to highly presensitized transplant recipients. Transplant Int 1:2–5
Sanfilippo FP, Vaughn WK, Peters TG, Bollinger RR, Spees EK (1983) Transplantation for polycystic kidney disease. Transplantation 36(1):54–59
Scheinman JI, Najarian JS, Mauer SM (1984) Successful strategies for renal transplantation in primary oxalosis. Kidney Int 25:804–811
Sinclair NRSC, Stiller CR, Jeffery JR, Keown PA (1988) Multivariate analysis of riks factors leading to kidney graft loss in cyclosporine-treated patients. Transplant Proc 20(1) [Suppl 1]: 350–352
Takiff H, Cicciarelli J, Yin L, Perasaki PI (1988) Benefit of histocompatibility in cyclosporine-treated recipients of first cadaveric renal transplants and implications for kidney sharing. Transplant Proc 20(1) [Suppl 1]:39–40
Tivari J, Terasaki PI, Mickey MR (1987) Factors influencin kidney graft survival in the cyclosporine era: a multivariate analysis. Transplant Proc 19(1):1839–1841
Wonigeit K (1985) Pharmakokinetik von Ciclosporin A und Bedeutung der Blutspiegelmessung für die Therapie. Internist 26:534–542
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bunzendahl, H., Frei, U., Grosse, H. et al. Renal transplant recipients. World J Urol 6, 66–69 (1988). https://doi.org/10.1007/BF00326617
Issue Date:
DOI: https://doi.org/10.1007/BF00326617